BONFANTI, PAOLO

BONFANTI, PAOLO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 280 (tempo di esecuzione: 0.028 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: results from a retrospective cohort study 01 - Articolo su rivista 2024 Lapadula, GiuseppeMezzadri, LucaAntolini, LauraBonfanti, Paolo +
Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort 02 - Intervento a convegno 2024 Bonfanti, P +
Central nervous system and neuropsychiatric adverse events in Women living with HIV treated with INSTI-based regimens 02 - Intervento a convegno 2024 Bonfanti, P +
Changes in body mass index and lipid profile in PWH switching to a regimen without TAF vs PWH continuing TAF. Data from a real-life setting 02 - Intervento a convegno 2024 Bonfanti, P +
Characteristics of long COVID after two years of follow-up in a previously hospitalized population 02 - Intervento a convegno 2024 Ferrara, MCFerrarese, CFoti, GLuppi, FStrepparava, MGBellelli, GBonfanti, P +
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 01 - Articolo su rivista 2024 Lapadula, GiuseppeBonfanti, Paolo +
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 01 - Articolo su rivista 2024 Faverio, PaolaBonfanti, Paolo +
CNS relapse risk in HIV-positive patients affected by DLBCL and HGBL – a retrospective study of the musthal cohort 02 - Intervento a convegno 2024 Rindone, GGambacorti Passerini, CBonfanti, PVerga, L +
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 01 - Articolo su rivista 2024 Puoti, MassimoBonfanti, PaoloLapadula, Giuseppe +
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 01 - Articolo su rivista 2024 Bonfanti, PaoloPuoti, Massimo +
Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort 01 - Articolo su rivista 2024 Corti, NicolòBonfanti, Paolo +
High-risk HPV genotypes are associated with anal cytologic abnormalities but not with malignant histological lesions in a cohort of people with HIV (PWH) 02 - Intervento a convegno 2024 Lapadula, GLeone, BEBraga, MBonfanti, P +
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 01 - Articolo su rivista 2024 Soria, AlessandroBresciani, ElenaTorsello, AntonioBonfanti, PaoloLapadula, Giuseppe +
It is time to rethink the approach to cardiovascular risk in people with HIV. 01 - Articolo su rivista 2024 Bonfanti, Paolo
Lipids, weight gain and body mass index in ARV experienced PLWH treated with doravirine-based treatments: a comparison between dual or triple regimens vs bictegravir based triple regimen 02 - Intervento a convegno 2024 Bonfanti, P +
Long COVID: lights and shadows on the clinical characterization of this emerging pathology 01 - Articolo su rivista 2024 Bonfanti, P +
Long-term durability of dolutegravir + darunavir/cobicistat dual regimen in highly antiretroviral-experienced people living with HIV (DoDaco study) 02 - Intervento a convegno 2024 Lapadula, GMezzadri, LBonfanti, P +
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 01 - Articolo su rivista 2024 Puoti, MBonfanti, PLapadula, G +
Low level viremia at the beginning and in course of long-acting treatment with injectable cabotegravir and rilpivirine 02 - Intervento a convegno 2024 Bonfanti, P +
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort 01 - Articolo su rivista 2024 Graziano, FrancescaGhilardi, GiuliaLapadula, GiuseppeRossi, EmanuelaValsecchi, Maria GraziaGalimberti, StefaniaBonfanti, Paolo +